Cue Health Inc.
HLTHQ · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.01 | 0.01 |
| FCF Yield | 0.00% | -121.09% | -23.85% | -86.82% |
| EV / EBITDA | -0.66 | 0.06 | -0.21 | 0.32 |
| Quality | ||||
| ROIC | -17.74% | -21.57% | -9.93% | -16.53% |
| Gross Margin | -62.29% | -90.14% | -26.91% | -196.54% |
| Cash Conversion Ratio | 0.19 | 0.27 | 0.51 | 0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -54.47% | -44.56% | -3.84% | 6,308,119.72% |
| Free Cash Flow Growth | 0.00% | -88.61% | 66.70% | 21.78% |
| Safety | ||||
| Net Debt / EBITDA | -0.07 | 0.25 | 2.43 | 1.14 |
| Interest Coverage | -297.55 | -189.78 | -143.97 | -270.61 |
| Efficiency | ||||
| Inventory Turnover | 1.19 | 2.55 | 0.35 | 0.43 |
| Cash Conversion Cycle | 42.56 | 23.86 | 219.61 | 197.46 |